22nd Century Group Operating Cycle 2011-2026 | XXII

Annual Operating Cycle 22nd Century Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
169	107	127	83.7	104	55.9	44.3	55.6	90.3	90	111	1.54 K	1.11 K	7.4 K	600

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
7.4 K	44.3	779

Quarterly Operating Cycle 22nd Century Group

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
171	168	118	-	106	89.6	102	-	441	343	274	-	76.8	64.8	43.8	-	49.8	48.3	58.9	27	53.7	60.4	48.5	10.9	44.1	48.6	50.5	11.1	58.2	52.6	61.4	14.7	80.8	96.2	20.4	1.12	1.21	1.32	1.39	1.59	85.5	2.03	3.79	-	616	-	-	-	6.24 K	-	-	-	-	-	-	-	20.4	44.2	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
6.24 K	1.12	231

Operating Cycle of other stocks in the Biotechnology industry

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Verastem VSTM	38.5	$ 5.04	-4.73 %	$ 349 M	USA
Voyager Therapeutics VYGR	14.8	$ 3.96	-4.12 %	$ 232 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	127	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	148	-	-	$ 789 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	107	$ 12.41	-11.1 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	11.5	$ 6.37	2.66 %	$ 1.07 B	Singapore
XBiotech XBIT	40.8	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	72.6	$ 54.48	-1.89 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	558	$ 5.4	-3.05 %	$ 866 M	USA
X4 Pharmaceuticals XFOR	46.1	$ 4.04	-6.26 %	$ 171 M	USA
Xencor XNCR	131	$ 11.42	-7.23 %	$ 848 M	USA
XOMA Corporation XOMA	23.6	$ 30.17	-1.18 %	$ 364 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Zai Lab Limited ZLAB	186	$ 18.0	2.8 %	$ 19.7 B	China